As of May 31, 2025, Stentys SA (STNT.PA) reports a Net Margin of -211.70%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Stentys SA's Net Margin
Over recent years, Stentys SA's Net Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2019-12-31 | -211.70% |
| 2018-12-31 | -60.72% |
| 2017-12-31 | -83.43% |
| 2016-12-31 | -114.22% |
| 2015-12-31 | -155.01% |
This steady improvement highlights how Stentys SA manages its overall profitability and cost control over time.
Comparing Stentys SA's Net Margin to Peers
To better understand Stentys SA's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Stentys SA (STNT.PA) | -211.70% |
| Biohit Oyj (BIOBV.HE) | 17.97% |
| Medicon Hellas SA (MEDIC.AT) | 12.20% |
| Arcoma AB (ARCOMA.ST) | 7.13% |
| Klea Holding (ALVMG.PA) | 6.57% |
| AdderaCare AB (ADDERA.ST) | 0.50% |
Compared to its competitors, Stentys SA's Net Margin is about average compared to peers, reflecting typical industry profitability.